Atrium extends Premier contract:
This article was originally published in Clinica
Hudson, New Hampshire-based cardiovascular device developer Atrium Medical has extended its agreement with US group purchasing organisation Premier for thoracic drainage products by another three years. Under the terms of the dual-source contract, which took effect on March 1, Atrium will supply Premier's hospital members with products from its entire chest drainage device range including more recent additions such as the Express Mini 500 - a waterless, lightweight chest drainage system designed to be worn by the patient- and the Pneumostat chest drain valve.
You may also be interested in...
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.
US FDA’s ‘Project Renewal’ requires lots of work and flexibility, Oncology Center of Excellence acknowledges. Side-benefit may be getting outside physicians to appreciate the value of drug labeling.
The pharmaceutical industry would lose bid to eliminate PUPSIT but win relaxed WFI in proposed EU GMP Annex I revision.